|
業務類別
|
Biotechnology |
|
業務概覽
|
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational sciencehas elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function. |
| 公司地址
| 1325 Boylston Street, Suite 401, Boston, MA, USA, 02215 |
| 電話號碼
| +1 857 321-8020 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.rapportrx.com |
| 員工數量
| 69 |
| Mr. Abraham N. Ceesay, M.B.A. |
Chief Executive Officer and Director |
美元 576.54K |
24/04/2025 |
| Dr. Jeffrey Sevigny, M.D. |
Chief Medical Officer |
-- |
24/04/2025 |
| Mr. Troy A. Ignelzi |
Chief Financial Officer and Principal Accounting Officer |
美元 468.46K |
24/04/2025 |
| Ms. Kathy Wilkinson |
Chief People Officer |
-- |
24/04/2025 |
| Dr. Swamy Yeleswaram, PhD |
Chief Development Officer |
-- |
24/04/2025 |
| Ms. Cheryl Gault |
Chief Operating Officer |
-- |
24/04/2025 |
| Mr. David Bredt, M.D.,PhD |
Chief Scientific Officer |
-- |
18/06/2025 |
|
|
| Dr. Ramiro Sanchez, M.D. |
Independent Director |
24/04/2025 |
| Ms. Wendy B. Young, PhD |
Independent Director |
24/04/2025 |
| Mr. Abraham N. Ceesay, M.B.A. |
Chief Executive Officer and Director |
24/04/2025 |
| Dr. Steven M. Paul, M.D. |
Chairman of the Board |
24/04/2025 |
| Dr. James I. Healy, M.D.,PhD |
Independent Director |
24/04/2025 |
| Dr. Reid M. Huber, PhD |
Director |
24/04/2025 |
| Dr. John M. Maraganore,PhD |
Independent Director |
24/04/2025 |
| Mr. Robert J. Perez |
Independent Director |
24/04/2025 |
| Mr. Paul M. Silva |
Independent Director |
24/04/2025 |
|
|
|
|